MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer
MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer
Recruiting · NCT07045571 · Registry updated 2025-07-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, disease, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Not stated | 2025-07-01 | NCT07045571 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Changhai Hospital | 141 |
| Ruijin Hospital | 454 |
| Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 91 |
| Yingbin Liu, MD, PhD, FACS | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Renji Hospital, Shanghai Jiaotong University School of Medicine | Shanghai | China | 7 |